Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in NVCT — Nuvectis Pharma, Inc.

CIK 1214717 BOSTON, MA
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$7,949,499
+$4,980,368 QoQ
Shares Held
432,273
+12.5% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 82 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. NVCT ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in NVCT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,949,499 432,273
2026-03-31 $2,969,131 384,105
2025-12-31 $2,748,380 364,024
2025-09-30 $1,960,912 325,733
2025-06-30 $2,131,429 285,332
2025-03-31 $1,322,203 135,333
2024-12-31 $428,704 79,243
2024-09-30 $501,412 79,716
2024-06-30 $336,926 53,227
2024-03-31 $1,103,129 134,528
2023-12-31 $1,098,019 131,657
2023-09-30 $1,671,356 129,663
2023-06-30 $1,797,199 112,536
2023-03-31 $459,138 35,022
2022-12-31 $235,260 31,368
2022-09-30 $222,916 31,441
2022-06-30 $268,430 23,967
2022-03-31 $109,831 14,822